Conference Programs

September 28-29

PRESENTED IN-PERSON & VIRTUALLY

Target Identification and Validation – Part 1

RNA as a Drug Target

PROTACs and Targeted Protein Degradation – Part 1

Antibodies Against Membrane Protein Targets – Part 1

GPCR-Based Drug Discovery

PRESENTED VIRTUALLY

3D Cellular Models

Immunology and Oncology: Emerging Drug Targets

September 29-30

PRESENTED IN-PERSON & VIRTUALLY

Target Identification and Validation – Part 2

Lead Generation Strategies

PROTACs and Targeted Protein Degradation – Part 2

Antibodies Against Membrane Protein Targets – Part 2

NASH and Fibrosis

PRESENTED VIRTUALLY

Small G Proteins

Preclinical Strategies and Models in Oncology